These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16611115)

  • 1. Treatment of recurrent epistaxis in HHT.
    Geisthoff UW; Fiorella ML; Fiorella R
    Curr Pharm Des; 2006; 12(10):1237-42. PubMed ID: 16611115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
    Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
    Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia.
    Lund VJ; Howard DJ
    Am J Rhinol; 1999; 13(4):319-22. PubMed ID: 10485021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Luk L; Mace JC; Bhandarkar ND; Sautter NB
    Int Forum Allergy Rhinol; 2014 Aug; 4(8):640-5. PubMed ID: 24719397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of epistaxis in hereditary hemorrhagic telangiectasia patients by argon plasma coagulation with local anesthesia.
    Pagella F; Semino L; Olivieri C; Corno S; Dore R; Draghi F; Lanzarini L; Vespro V; Buscarini E; Danesino C
    Am J Rhinol; 2006; 20(4):421-5. PubMed ID: 16955772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
    Mahoney EJ; Shapshay SM
    Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management.
    Sautter NB; Smith TL
    Int Forum Allergy Rhinol; 2012; 2(5):422-31. PubMed ID: 22566463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy for epistaxis by hereditary hemorrhagic teleangiectasia: A 3-year follow up study on 45 patients.
    Papaspyrou G; Hecker D; Linxweiler M; Schick B; Al Kadah B
    J Craniomaxillofac Surg; 2017 Aug; 45(8):1179-1182. PubMed ID: 28615135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epistaxis in patients with hereditary hemorrhagic teleangiectasia].
    Jovancević L; Mitrović SM
    Med Pregl; 2006; 59(9-10):443-9. PubMed ID: 17345820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal self-packing for epistaxis in Hereditary Hemorrhagic Telangiectasia increases quality of life.
    Droege F; Lueb C; Thangavelu K; Stuck BA; Lang S; Geisthoff U
    Rhinology; 2019 Jun; 57(3):231-239. PubMed ID: 30739126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy assessment of current treatment options for epistaxis in HHT.
    Dür C; Anschuetz L; Negoias S; Bulut OC; Angelillo-Scherrer A; Caversaccio M
    Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4321-4328. PubMed ID: 33661356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia.
    Kuan EC; Peng KA; Thompson CF; Suh JD; Wang MB
    Lasers Med Sci; 2017 Apr; 32(3):527-531. PubMed ID: 28116537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary hemorrhagic telangiectasia-laser treatment of epistaxis.
    Poje G; Kavanagh MM
    Ear Nose Throat J; 2017 Sep; 96(9):E10-E14. PubMed ID: 28931195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia.
    Bergler W; Riedel F; Baker-Schreyer A; Juncker C; Hörmann K
    Laryngoscope; 1999 Jan; 109(1):15-20. PubMed ID: 9917033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Harvey RJ; Kanagalingam J; Lund VJ
    Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Office-based sclerotherapy for recurrent epistaxis due to hereditary hemorrhagic telangiectasia: a pilot study.
    Boyer H; Fernandes P; Duran O; Hunter D; Goding G
    Int Forum Allergy Rhinol; 2011; 1(4):319-23. PubMed ID: 22287439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT).
    Al Kadah B; Papaspyrou G; Schneider M; Schick B
    Eur Arch Otorhinolaryngol; 2015 Jan; 272(1):117-22. PubMed ID: 24854232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Hitchings AE; Lennox PA; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cauterization for epistaxis in hereditary hemorrhagic telangiectasia.
    Dabiri J; Fakhoury R; Choufani G; Mine B; Hassid S
    B-ENT; 2016; 12(1):9-16. PubMed ID: 27097388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.